⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5924143 | 0.78 | — | — | |
| SCHEMBL18643602 | 0.75 | — | — | |
| SCHEMBL19416598 | 0.68 | — | — | |
| SCHEMBL22844376 | 0.68 | — | — | |
| SCHEMBL21737563 | 0.68 | — | — | |
| SCHEMBL1975403 | 0.67 | — | — | |
| SCHEMBL215024 | 0.67 | — | — | |
| SCHEMBL408921 | 0.67 | — | — | |
| Acetamidine SCHEMBL48895 | 0.64 | — | — | |
| Acetamidine SCHEMBL31197659 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020264495-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2020-12-30 | — | — | WO | disclosed |